Proposals for Clinical Trials & Correlative Studies

Submit a New Study Concept 

  • Proposals for clinical trials may be submitted from members of BMT CTN Core Centers, Affiliate Clinical Centers or others outside the Network. 
  • Parties interested in submitting a proposal for consideration may complete the Proposed New Study Concept Form and return it to bmtctn@emmes.com.

Ancillary Studies and Secondary Data Analyses

An ancillary study entails the collection from study participants of data and/or specimens, or the conduct of additional analyses of existing materials or samples that are outside the specific objectives of the primary study. Information about Network ancillary studies can be found in the Manual of Procedures, Chapter 11; a summary of the ancillary study review and approval process is also available.

A secondary analysis uses previously collected data from BMT CTN studies to look at objectives other than those addressed in the original studies. Information about Network Ancillary Studies can be found in the Manual of Procedures, Chapter 12.

To assist in study planning, a demographic characteristic summary of each closed BMT CTN trial cohort is available.

To submit a correlative research proposal, please submit the completed BMT CTN Correlative Study Proposal form by email to bmtctn_nmdp@nmdp.org.

Please note that research materials (biospecimens and clinical data) will only be provided following proposal approval by the BMT CTN Executive Committee. Additional information may be found in the Manual of Procedures.

BMT CTN Research Sample Collections

The BMT CTN supports investigators engaged in retrospective immunogenetic and immunobiological studies in Hematopoietic cell transplantation (HCT) / Cellular Therapy (CT) by providing access to numerous research samples and clinical data collected during our BMT CTN clinical trials. Protocol-specific links provide investigators with the following resources:

  • Clinical protocols to review primary and secondary endpoints and other relevant clinical data collected in each trial.
  • Information regarding the prospective collection schedule for research samples, sample processing, and sample storage parameters.
  • Protocol-specific research sample collection summaries to facilitate initial assessments of available research samples for future ancillary study planning.
  • Overview of BMT CTN procedures for reviewing and approving ancillary study proposals and current proposal submission form.
Coming Soon: Collections in Progress
Protocol Sort ascending Sample Types and Collection Schedule Biospecimen Availability Summary Link to Biospecimen Availability
2101 - CIBMTR SC21-07/BMT CTN 2101 Observational Study PDF PDF
1902 - MM CAR-T to Upgrade Response PDF PDF
1703-1801- PROGRESS III - PTCY vs. TAC/MTX PDF PDF
1301 - CNI-free GVHD (PROGRESS II) PDF PDF
BMT CTN Biorepository
Protocol Sort ascending Sample Types and Collection Schedule Biospecimen Availability Summary Link to Biospecimen Availability
1502 - CHAMP PDF PDF
1501 - SR aGVHD PDF PDF
1401 - Myeloma Vaccine PDF PDF
1302 - Allo Myeloma PDF PDF
1204 - RICHI PDF PDF
1203 - GVHD Prophylaxis (PROGRESS I) PDF PDF
1202 - Biomarkers PDF PDF
1102 - MDS PDF PDF
1101 - Double Cord vs. Haplo PDF PDF
0901 - Full vs RIC in MDS/AML PDF PDF
0802 - aGVHD Phase III PDF PDF
0801 - cGVHD Treatment PDF PDF
07LT - 0702 LTFU PDF PDF
0702 - STaMINA (multiple myeloma) PDF PDF
0701 - Follicular NHL PDF PDF
0401 - Bexxar/BEAM PDF PDF
0302 - Acute GVHD PDF PDF
0201 - URD PB vs BM (Donor Samples Only) PDF PDF
ACSR Repository
Protocol Sort ascending Sample Types and Collection Schedule Biospecimen Availability Summary Link to Biospecimen Availability
0903 - Allo Transplant in HIV PDF -
0803 - Auto Transplant in HIV PDF -
NHLBI Repository
Protocol Sort ascending Sample Types and Collection Schedule Biospecimen Availability Summary Link to Biospecimen Availability
0402 - GVHD Prophylaxis PDF -
0201 - URD PB vs BM (Patient Samples Only) PDF -
0101 - Fungal Prophylaxis PDF -